Collectively, these findings indicate that loss of Exoc5 impairs PTC regeneration and exacerbates fibrosis in the injured kidney, suggesting its therapeutic potential in preventing the transition from acute kidney injury (AKI) to chronic kidney disease (CKD). Here, EXOC5 is linked to chronic kidney disease.